Recent Blog Articles
Taking up adaptive sports
Cutting and self-harm: Why it happens and what to do
Discrimination at work is linked to high blood pressure
Pouring from an empty cup? Three ways to refill emotionally
Give praise to the elbow: A bending, twisting marvel
Sneezy and dopey? Seasonal allergies and your brain
The FDA relaxes restrictions on blood donation
Apps to accelerometers: Can technology improve mental health in older adults?
Swimming and skin: What to know if a child has eczema
A muscle-building obsession in boys: What to know and do
Charlie Schmidt
Editor, Harvard Medical School Annual Report on Prostate Diseases
Charlie Schmidt is an award-winning freelance science writer based in Portland, Maine. In addition to writing for Harvard Health Publishing, Charlie has written for Science magazine, the Journal of the National Cancer Institute, Environmental Health Perspectives, Nature Biotechnology, and The Washington Post.
Posts by Charlie Schmidt
Cancer
Yoga improves treatment-related symptoms in men with prostate cancer
Men's Health
Combination hormonal therapy boosts survival in men with aggressive prostate cancer
Men's Health
Influential task force revises its position on PSA screening tests
Charlie Schmidt
Combining surgery, radiation, and hormonal therapy dramatically extends survival in men with advanced prostate cancer
Cancer
Combining surgery, radiation, and hormonal therapy dramatically extends survival in men with advanced prostate cancer
Charlie Schmidt
Adding hormonal therapy to radiation lengthens survival in men with recurring prostate cancer
Cancer
Adding hormonal therapy to radiation lengthens survival in men with recurring prostate cancer
Cancer
New imaging technique may help some men avoid prostate biopsy
Cancer
Immediate radiation when PSA levels spike after prostate cancer surgery helps reduce risk of recurrence
Men's Health
New study recommends immediate radiation when PSA Levels spike after prostate cancer surgery
Cancer
Treatment versus monitoring of prostate cancer: Survival rates the same after 10 years
Men's Health
Treatment versus monitoring of prostate cancer: Survival rates the same after 10 years
Charlie Schmidt
Treating the primary tumor can improve survival in men whose prostate cancer has spread
Cancer
Treating the primary tumor can improve survival in men whose prostate cancer has spread
Cancer
New urine test predicts high-grade prostate cancer
Charlie Schmidt
New urine test predicts high-grade cancer
Cancer
The risks of active surveillance for men with intermediate-risk prostate cancers
Men's Health
Risks of active surveillance for men with intermediate-risk prostate cancers
Charlie Schmidt
Long-term hormonal therapy benefits men with locally advanced prostate cancer
Cancer
Long-term hormonal therapy benefits men with locally advanced prostate cancer
Men's Health
Promising results for a targeted drug in advanced prostate cancer
Charlie Schmidt
Does fewer PSA tests mean less prostate cancer?
Cancer
Does fewer PSA tests mean less prostate cancer?
Cancer
